BASEL, Switzerland, Jan. 03, 2024 (GLOBE NEWSWIRE) Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management will attend and present at two upcoming conferences in San Francisco, CA. SACHS 7th Annual Neuroscience Innovation ForumFormat: Panel DiscussionTitle: Exploring New Modalities for Rare & Orphan Neurological DiseasesDate: Sunday, January 7, 2024 Time: 11:00 a.m. PST (2:00 p.m. EST/8:00 p.m. CE
Harvey J. Berger, M.D. Joins Kojin Therapeutics as Chairman, President, and Chief Executive Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
A more diverse cast of entrepreneurs is only one of the changes underway at the Cambridge nonprofit, which has expanded rapidly amid fluctuating vacancy rates and longer stays by belt-tightening biotech companies.
The formal launch of Tome and its buyout of Replace Therapeutics come just as regulators in the US and Europe have approved the first gene-editing drug.